Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

SANUWAVE Health (SNWV) EBIT (2023 - 2025)

SANUWAVE Health (SNWV) has disclosed EBIT for 8 consecutive years, with $1.9 million as the latest value for Q2 2025.

  • On a quarterly basis, EBIT fell 5.77% to $1.9 million in Q2 2025 year-over-year; TTM through Jun 2025 was $11.8 million, a 1092.06% increase, with the full-year FY2024 number at $5.4 million, up 1103.15% from a year prior.
  • EBIT was $1.9 million for Q2 2025 at SANUWAVE Health, up from $986000.0 in the prior quarter.
  • In the past five years, EBIT ranged from a high of $4.6 million in Q4 2024 to a low of -$1.0 million in Q1 2024.